Performance evaluation of a new on-demand molecular test for the rapid identification of severe acute respiratory syndrome coronavirus 2 in pediatric and adult patients.
COVID-19
RT-PCR testing
SARS-CoV-2
comparative diagnostic accuracy
molecular diagnosis
Journal
Frontiers in microbiology
ISSN: 1664-302X
Titre abrégé: Front Microbiol
Pays: Switzerland
ID NLM: 101548977
Informations de publication
Date de publication:
2022
2022
Historique:
received:
21
07
2022
accepted:
20
09
2022
entrez:
21
11
2022
pubmed:
22
11
2022
medline:
22
11
2022
Statut:
epublish
Résumé
The rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has increased the need to identify additional rapid diagnostic tests for an accurate and early diagnosis of infection. Here, we evaluated the diagnostic performance of the cartridge-based reverse transcription polymerase chain reaction (RT-PCR) test STANDARD M10 SARS-CoV-2 (SD Biosensor Inc., Suwon, South Korea), targeting the ORF1ab and E gene of SARS-CoV-2, and which can process up to eight samples in parallel in 60 min. From January 2022 to March 2022, STANDARD™ M10 assay performance was compared with Xpert
Identifiants
pubmed: 36406396
doi: 10.3389/fmicb.2022.999783
pmc: PMC9670180
doi:
Types de publication
Journal Article
Langues
eng
Pagination
999783Informations de copyright
Copyright © 2022 Colagrossi, Costabile, Scutari, Cento, Coltella, Reale, Scilipoti, Villani, Alteri, Perno and Russo.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Sci Rep. 2022 Jul 27;12(1):12814
pubmed: 35896675
BMC Infect Dis. 2021 Feb 17;21(1):184
pubmed: 33596855
Pediatrics. 2012 Jun;129 Suppl 3:S153-60
pubmed: 22661762
J Infect Dis. 2021 Apr 8;223(7):1139-1144
pubmed: 33394052
Future Microbiol. 2022 Apr;17:417-424
pubmed: 35350884
J Clin Med. 2022 Apr 27;11(9):
pubmed: 35566591
Diagn Microbiol Infect Dis. 2021 Apr;99(4):115208
pubmed: 33545455
Emerg Microbes Infect. 2020 Dec;9(1):1259-1268
pubmed: 32438868
J Clin Microbiol. 2020 Jul 23;58(8):
pubmed: 32366669
J Mol Biol. 2021 Sep 3;433(18):167155
pubmed: 34273397
Expert Rev Vaccines. 2021 Oct;20(10):1201-1209
pubmed: 34488546
mBio. 2022 Apr 26;13(2):e0297921
pubmed: 35352979
Nat Med. 2021 Apr;27(4):717-726
pubmed: 33664494
J Clin Virol. 2020 Dec;133:104660
pubmed: 33126109
Lancet Infect Dis. 2020 Sep;20(9):e238-e244
pubmed: 32628905
Elife. 2021 Jul 12;10:
pubmed: 34250907
J Clin Microbiol. 2020 Jul 23;58(8):
pubmed: 32381643
Lancet Infect Dis. 2021 Apr;21(4):e78
pubmed: 32795410
Emerg Microbes Infect. 2020 Dec;9(1):1175-1179
pubmed: 32448084
Lancet. 2020 Feb 15;395(10223):470-473
pubmed: 31986257
J Pathol Clin Res. 2021 Mar;7(2):135-143
pubmed: 33185036
Infect Dis Ther. 2020 Sep;9(3):573-586
pubmed: 32725536
Cochrane Database Syst Rev. 2021 Mar 24;3:CD013705
pubmed: 33760236
J Clin Virol. 2020 Jul;128:104428
pubmed: 32434706
Lancet Infect Dis. 2020 Aug;20(8):e192-e197
pubmed: 32539990
Microbiol Spectr. 2022 Jun 29;10(3):e0103322
pubmed: 35665629
Infect Chemother. 2022 Jun;54(2):360-363
pubmed: 35706076
J Clin Virol. 2020 Aug;129:104501
pubmed: 32619959
PLoS One. 2020 Sep 8;15(9):e0236311
pubmed: 32898153
Lancet Infect Dis. 2021 Sep;21(9):e290-e295
pubmed: 33636148